Use of rapamycin in treatment of tumors
US5206018A · kind A · utility
105Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 1991 |
| Grant date | Apr 27, 1993 |
| Priority date | — |
| Expiry date | Oct 29, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/765
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of treating, inhibiting the proliferation of, reducing the size of, or eradicating malignant neoplasms in a mammal in need thereof which comprises administering an antineoplastic amount of rapamycin to said mammal. In particular, rapamycin is useful in treating, inhibiting the proliferation of, reducing the size of, or eradicating malignant mammary and skin carcinomas, and central nervous system neoplasms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.